COBAS 4800 HPV TEST, CE-IVD 05235901190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2012-05-10 for COBAS 4800 HPV TEST, CE-IVD 05235901190 manufactured by Roche Molecular Systems.

Event Text Entries

[9871332] The customer alleged that 2 patient samples generated discrepant results with the cobas 4800 hpv amp/det 240t ce-ivd test as compared to a comparator test (digene-qiagen) for (b)(6) detection. This report is for sample number 4431859130, mdr 2243471-2012-00021 was filed for sample number (b)(4). Specifically the cobas 4800 hpv amp/det 240t ce-ivd generated (b)(6) results for (b)(6) and the comparator test generated (b)(6) results for (b)(6). Investigative testing of the complaint sample using the cobas 4800 hpv test generated the same valid (b)(6) results as reported by the customer. Kit batch retain testing met specification. The high pure hpv dna test by digene- qiagen is a nucleic acid hybridization assay with signal amplification that utilizes microplate chemiluminescent detection. This unit of measure uses the amount of emitted light and is measured as relative light units (rlus) on a luminometer. The intensity of the light emitted denotes the presence or absence of target dna in the specimen. The cobas 4800 hpv test uses real time pcr technology and measure the fluorescence emitted of the polymerase chain reaction. The number of cycles at which the relative fluorescence exceeds the threshold is the threshold cycle (ct). These two units of measure are not directly comparable. The hybrid capture hpv dna test measures its limit of detection in pg/ml (a unit of mass density) and the cobas 4800 hpv test measures its limit of detection in copies /ml (a unit of viral load). These two units and test results are not directly comparable. The differences seen between the assays could be due, but not limited to, sensitivity differences between the tests, the ability of the digene-qiagen test to detect low risk hpv genotypes , and sample collection methods. The cobas 4800 hpv test performed as expected. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[20917373] A customer site in (b)(6) is alleging discrepant results were generated with the cobas 4800 hpv amp/det 240t ce-ivd and a comparator test (digene-qiagen) for hpv detection. Specifically the cobas 4800 hpv amp/det 240t ce-ivd generated negative results for hpv 16, hpv 18 and other high risk hpv and the comparator test generated positive results for hpv 16, hpv 18, and other high risk hpv. The sample was first tested on (b)(6) 2012 and repeat testing was performed on (b)(6) 2012. The repeat test confirmed the original results.
Patient Sequence No: 1, Text Type: D, B5


[21150653] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of the investigation will be communicated through a follow-up report. The related us-ivd cobas 4800 hpv test is m/n (b)(4). Pma p100020. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2012-00022
MDR Report Key2568747
Report Source01,05
Date Received2012-05-10
Date of Report2012-05-25
Date of Event2012-04-03
Date Mfgr Received2012-05-25
Date Added to Maude2012-09-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use0
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS 4800 HPV TEST, CE-IVD
Generic NameKIT, DNA DETECTION, HUMAN PAPILLOMA VIRUS
Product CodeMAQ
Date Received2012-05-10
Catalog Number05235901190
Lot NumberP09699
Device Expiration Date2012-11-29
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2012-05-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.